|
Index of reports
> Life Threatening Events (39)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 39 Next >>
Possible Risperdal Consta side effects in female
Reported by a physician from France on 2012-08-06
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Cerebrovascular Accident, Viith Nerve Paralysis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Tegretol
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a physician from Canada on 2012-08-01
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Surgery, Suicide Attempt, Multiple Fractures
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Celexa
Dosage: every day before noon
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-01
Celexa
Administration route: Oral
End date: 2012-03-15
Invega Sustenna
Dosage: 4/52
End date: 2012-06-22
Invega Sustenna
Start date: 2012-04-24
Invega Sustenna
Start date: 2012-03-27
Invega Sustenna
Dosage: initiated an day-8, after initiation dose
Indication: Schizophrenia
Start date: 2012-05-22
Olanzapine
Dosage: every night
Administration route: Oral
Indication: Acute Psychosis
Olanzapine
Dosage: every night at bed time x every 2 weeks
Administration route: Oral
End date: 2012-02-01
Olanzapine
Dosage: every night x once every 2 weeks
Administration route: Oral
Start date: 2012-01-12
Risperdal Consta
Start date: 2011-05-01
Risperdal Consta
Start date: 2012-03-13
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-15
Risperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-23
Patient: male
Reactions: Ischaemic Stroke, Psychiatric Decompensation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Loxapine HCL
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-11-23
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-16
Risperdal Consta
Indication: Persecutory Delusion
Start date: 2010-12-03
End date: 2010-12-03
Tercian
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-12-02
Zyprexa
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-11-23
Other drugs received by patient: Imovane; Lepticur; Lepticur; Polyethylene Glycol; Escitalopram
Possible Risperdal Consta side effects in 35 year old male
Reported by a physician from Australia on 2012-07-20
Patient: 35 year old male
Reactions: Akathisia, Therapeutic Response Decreased, Incorrect Dose Administered, Cardiomyopathy, Delirium
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Clozapine
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-01
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in 41 year old male
Reported by a physician from Germany on 2012-06-18
Patient: 41 year old male
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2012-03-01
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-02-29
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-12
End date: 2012-04-12
Risperdal Consta
Start date: 2012-03-29
End date: 2012-03-29
Other drugs received by patient: Lorazepam; Bisoprolol Fumarate; Remergil; Remergil; Lorazepam; Remergil; Remergil; Venlafaxine Hydrochloride; Remergil; Lorazepam; Lorazepam; Lorazepam; Venlafaxine Hydrochloride
Possible Risperdal Consta side effects in female
Reported by a physician from Canada on 2012-06-11
Patient: female, weighing 63.5 kg (139.7 pounds)
Reactions: Inappropriate Schedule of Drug Administration, Hodgkin's Disease
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Concerta
Dosage: 50 (unit unspecified)
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2011-09-01
Risperdal Consta
Indication: Psychotic Disorder
Start date: 2011-09-01
Other drugs received by patient: Clonazepam
Possible Risperdal Consta side effects in female
Reported by a physician from Canada on 2012-06-05
Patient: female, weighing 63.5 kg (139.7 pounds)
Reactions: Inappropriate Schedule of Drug Administration, Hodgkin's Disease
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Concerta
Dosage: 50 (unit unspecified)
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2011-09-01
Risperdal Consta
Indication: Psychotic Disorder
Other drugs received by patient: Clonazepam
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-04
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Sepsis, Malnutrition, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal Consta side effects in female
Reported by a physician from China on 2012-05-18
Patient: female
Reactions: Ventricular Tachycardia, Atrial Fibrillation, Arrhythmia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-11-01
End date: 2011-01-01
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-11-18
End date: 2010-12-18
Risperidone
Administration route: Oral
Risperidone
Dosage: 2~3ml/d
Administration route: Oral
Risperidone
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-11-18
End date: 2011-02-18
Possible Risperdal Consta side effects in 49 year old male
Reported by a physician from Japan on 2012-05-11
Patient: 49 year old male, weighing 45.0 kg (99.0 pounds)
Reactions: Dysphagia, Cyanosis, Hypoglycaemia, Sepsis, Coma, Parkinsonism
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2008-06-08
End date: 2010-12-07
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-12-21
End date: 2010-12-21
Other drugs received by patient: Alosenn; Levomepromazine Maleate; Magnesium Oxide; Anginal
Possible Risperdal Consta side effects in female
Reported by a physician from China on 2012-05-02
Patient: female
Reactions: Ventricular Tachycardia, Atrial Fibrillation, Arrhythmia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-11-01
End date: 2011-01-01
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-11-18
End date: 2010-12-18
Risperidone
Dosage: 2~3ml/d
Administration route: Oral
Risperidone
Administration route: Oral
Risperidone
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-11-18
End date: 2011-02-18
Possible Risperdal Consta side effects in female
Reported by a health professional (non-physician/pharmacist) from NEW Zealand on 2012-04-27
Patient: female
Reactions: Road Traffic Accident, Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a pharmacist from United Kingdom on 2012-03-27
Patient: male
Reactions: Respiratory Failure, Pancreatitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-23
Patient: 36 year old female
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 49 year old male
Reported by a physician from Japan on 2012-03-07
Patient: 49 year old male, weighing 45.0 kg (99.0 pounds)
Reactions: Dysphagia, Sepsis, Hypoglycaemia, Coma
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-12-21
End date: 2010-12-21
Risperdal Consta
Start date: 2008-06-08
End date: 2010-12-07
Other drugs received by patient: Anginal; Alosenn; Magnesium Oxide; Levomepromazine Maleate
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-06
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal Consta side effects in female
Reported by a pharmacist from Netherlands on 2012-02-29
Patient: female
Reactions: Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal Consta side effects in female
Reported by a pharmacist from Netherlands on 2012-02-23
Patient: female
Reactions: Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-17
Patient: 48 year old male
Reactions: Pulmonary Embolism, Toxicity To Various Agents, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Havlane (Loprazolam Mesilate)
Dosage: ;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-02
End date: 2011-06-02
Lepticur (Tropatepine Hydrochloride)
Dosage: 10 mg; bid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
End date: 2011-06-01
Mirtazapine
Dosage: 15 mg;bid;po; 15 mg;qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-07
Risperdal
Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-04-01
Risperdal
Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-07
End date: 2011-06-10
Risperdal
Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-10
End date: 2011-06-29
Risperdal Consta
Dosage: 3.3333 mg;qd;im
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-15
End date: 2011-06-29
Sulfarlem (Anethole Trithione)
Dosage: 150 mg; qd; po
Administration route: Oral
Indication: Aptyalism
Start date: 2011-05-01
Trimeprazine Tartrate
Dosage: 10 gtt;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
End date: 2011-06-01
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-13
Patient: male
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Havlane
Dosage: one box
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2011-06-02
End date: 2011-06-02
Lepticur
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2011-05-01
End date: 2011-06-01
Mirtazapine
Administration route: Oral
Indication: Ill-Defined Disorder
Risperdal
Administration route: Oral
Start date: 2011-04-01
End date: 2011-06-10
Risperdal
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2011-06-10
End date: 2011-06-29
Risperdal Consta
Indication: Ill-Defined Disorder
Start date: 2011-06-15
End date: 2011-06-29
Sulfarlem
Administration route: Oral
Indication: Aptyalism
Start date: 2011-05-01
Trimeprazine Tartrate
Administration route: Oral
Indication: Ill-Defined Disorder
Start date: 2011-05-01
End date: 2011-06-01
Possible Risperdal Consta side effects in female
Reported by a physician from Germany on 2012-01-20
Patient: female, weighing 80.0 kg (176.0 pounds)
Reactions: Basal Ganglia Infarction, Drug Interaction, Hemiparesis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2011-10-12
End date: 2011-10-12
Risperdal Consta
Indication: Psychotic Disorder
End date: 2011-09-14
Risperdal Consta
Start date: 2011-09-28
End date: 2011-09-28
Other drugs received by patient possibly interacting with the suspect drug:
Zopiclon
Administration route: Oral
Indication: Sleep Disorder
Other drugs received by patient: Seroquel; Mirtazapine; Mirtazapine
Possible Risperdal Consta side effects in male
Reported by a physician from Japan on 2012-01-05
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Shock Haemorrhagic, Schizophrenia, Emotional Disorder, Treatment Noncompliance, Gastric Ulcer
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Start date: 2010-07-07
End date: 2010-10-19
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-10-20
End date: 2011-05-30
Other drugs received by patient: Depakene; Lonasen; Rohypnol; Senevacul; Lonasen; Magnesium Sulfate
Possible Risperdal Consta side effects in 52 year old male
Reported by a physician from Japan on 2011-12-23
Patient: 52 year old male
Reactions: Hyponatraemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 18 year old male
Reported by a pharmacist from United States on 2011-12-20
Patient: 18 year old male, weighing 105.9 kg (233.0 pounds)
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a physician from France on 2011-12-09
Patient: male
Reactions: Psychotic Disorder, Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Administration route: Oral
Indication: Psychotic Disorder
Imovane
Administration route: Oral
Indication: Insomnia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-09-08
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-07
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Page 1 Next >>
|
